Author Guidelines

The Journal of Bone and Mineral Research (JBMR) is a peer-reviewed journal providing a forum for papers of the highest quality pertaining to all areas of the biology and physiology of bone, the hormones that regulate bone and mineral metabolism, and the pathophysiology and treatment of disorders of bone and mineral metabolism. The Journal aims to publish the very best of basic, translational and clinical research in the bone field.

Editorial Policies and Practices
Review Process
“Accepted Article” Publication (formerly WebFirst)
Types of Submissions Accepted
Submitting a Manuscript
Editorial Manager™ Online Submissions and Review System
Manuscript Format
Author Fees
Key Words
 

Editorial Policies and Practices

Acceptance Rate: JBMR accepts no more than 30% of manuscripts submitted.

Animal Studies: It is the responsibility of the authors to assure that their experimental procedures are in compliance with the guiding principles in the "Care and Use of Animals" (published each month in the Information for Authors of the American Journal of Physiology or available online at http://www.nap.edu/books/0309053773/html/) and to document that these studies were approved by the appropriate institutional animal care and oversight committee.

Authorship: To qualify for authorship, each author should contribute substantially to the intellectual content of the work. Such contribution consists of: 1) participating in the conception and design or analysis and interpretation of data; 2) drafting the article or critically revising it; and 3) approving the final version submitted, and approving any subsequent revisions. All three conditions must be met to justify authorship. Each author is required to register on the Editorial Manager site and sign the Copyright Transfer Agreement Form indicating their agreement with the submission of the manuscript.

Clinical Trials: To ensure transparency of clinical trial endpoints and preplanned statistical analyses, any manuscript submitted to the JBMR referencing a study for which recruiting started on or after January 1, 2006, must have been registered at http://www.clinicaltrials.gov. Trial data may be submitted by sponsors legally responsible for conducting clinical trials, governmental or international agencies conducting or supporting clinical trials, and lead principal investigators who are responsible for conducting and coordinating the overall clinical study. For multisite studies, submission of data should be coordinated among the sites so that clinicaltrials.gov does not receive multiple copies of the same trial. Each trial should follow the World Health Organization standard for minimal registration data set (http://www.icmje.org/clin_trialup.htm#table1). For more information, please see the frequently asked questions from clinicaltrials.gov (http://prsinfo.clinicaltrials.gov/faq.html or visit http://www.clinicaltrials.gov/). Authors must state in their cover letter that their study has been submitted to the clinical trials registry. Please include their unique trial number and their trial registration date. Authors must also include their unique trial number and their trial registration date on the title page of their manuscript.

Conflict of Interest: Authors are required to disclose any financial interests, direct or indirect (dual commitment), that might affect the conduct or reporting of the work they have submitted. Such financial interests may take the form of corporate appointments, consultancies, stock ownership, other equity interests or patent licensing arrangements with companies mentioned in or related to the subject matter of the article being submitted. If the authors are uncertain about what might be a dual commitment, they should err on the side of full disclosure. Such financial interests should be disclosed to the Editor-in-Chief in the cover letter, on a separate conflict of interest page in the manuscript and on the conflict of interest forms accompanying the article at the time of submission (for an example of how to format the conflict of interest page in your manuscript, see under "Manuscript Format" below). The conflicts of interest disclosed on the conflict of interest form should be the same as those disclosed on the conflict of interest page in the manuscript.

It is the responsibility of the corresponding author to ensure that all co-authors provide the necessary disclosure information. Conflict of Interest forms can be found on the online submission site (http://jbmr.editorialmanager.com) and on the JBMR website (http://www.jbmr.org/view/0/authorForms.html). Information regarding dual commitments may be made available to reviewers. Conflict of interest information will be published for all accepted manuscripts.

Copyright: The copyright for material published in the Journal of Bone and Mineral Research is held by the American Society for Bone and Mineral Research.

American Association of Medical Colleges Guidelines: In September of 2006, the ASBMR Council voted to adopt the AAMC “Principles for Protecting Integrity in the Conduct and Reporting of Clinical Trials.” Please find a list of these guidelines located here.

Please read over the guidelines to ensure that your manuscript and study comply with these principles. We now require that you initial a line on the conflict of interest form stating that your study has complied with a pre-specified analysis. Additionally, each manuscript must disclose, on the conflict of interest page, the role each author has played in conducting the study and preparation of the manuscript.

Duplicate Publication: JBMR will not accept duplicate publication of scientific data. If closely related papers could be considered as duplicate publications, they should be submitted with the original manuscript and the authors should provide documentation to justify the originality of the newly submitted manuscript.

Human Subject Studies: It is the responsibility of the authors to assure that all clinical investigations detailed in manuscripts submitted to JBMR are conducted in accordance with the Declaration of Helsinki (printed in each copy of the Journal) and to document that these studies have been approved by the appropriate institutional human research committee. Identifying information within written descriptions, photographs or pedigrees should not be published. If such information is included as essential scientific information, the authors must submit written consent of patient or guardian to publish such photographs in the print and electronic versions of the journal.
 
NIH-Funded Studies: Wiley-Blackwell will support our authors by posting the accepted version of articles by NIH grant-holders to PubMed Central upon acceptance by the journal. The accepted version is the version that incorporates all amendments made during peer review, but prior to the publisher’s copy-editing and typesetting. This accepted version will be made publicly available 12 months after publication. The NIH mandate applies to all articles based on research that has been wholly or partially funded by the NIH and that are accepted for publication on or after April 7, 2008.

NIH authors should be aware that they will receive an e-mail request once Wiley-Blackwell has posted the files of their accepted manuscript to the NIH Manuscript Submission system to approve the upload for display on the PubMed Central system. This is a requirement of their grant/affiliation.

For NIH employees only, Wiley-Blackwell will accept the NIH Publishing Agreement. The societies for whom we publish may decide on a different policy. We will continue to brief them on any discussions that we have with the NIH regarding the processing of the articles, appropriate acknowledgements with citation and linking to the final published version on the publisher’s site, and clear licensing terms and conditions for the use of copyrighted material.
In addition, Wiley-Blackwell will continue to consult directly with authors, editors and society partners to determine how we as their publisher may best support them going forward.

Prior Publication: JBMR will accept original manuscripts that contain material that has not been reported elsewhere, except in the form of an abstract of not more than 400 words, or an alternative short communication. If any preliminary report other than an abstract has been published or submitted, copies must be submitted with the manuscript and this must be noted in the cover letter to the editor. Prior abstract presentations must be described in a footnote to the title. Initial submissions must be accompanied by the copyright assignment form (located in the back of the Journal), with original signatures of all authors.

Responsibilities of Reviewers: External peer reviewers should disclose to the Editor-in-Chief any potential conflicts of interest that could bias their opinions of the manuscript. They should disqualify themselves from reviewing specific manuscripts if they believe it to be appropriate, or accept the decision of the Editor-in-Chief, who may elect to consult a designated expert in the subject area of the manuscript regarding disqualification if there is any question regarding a potential conflict of interest. The critical review of manuscripts is an essential component of the scientific publication process, to which every scientist can and should contribute. The review should comprise a critical but impartial scientific and literary appraisal in the fields of your knowledge and skills. You should not review a manuscript outside your expertise or where a personal, scientific or financial interest could be considered likely to bias your judgment. If you have any doubts about these matters please contact the Editorial Office.

As a reviewer, you may not use or disclose any unpublished content of a manuscript under review without the express written permission of the Authors obtained through the Editorial office. Under special circumstances, you may wish to consult a collaborator or colleague on some special point. Please clear this with the Editorial Office and then note this fact, and the name of the collaborator or consultant, in your comments to the Editor in your review.

Sequence Data: If submitted manuscripts describe original nucleotide/amino acid sequence data, these data should be submitted to GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html) by the authors, and the accession numbers should be included with the submitted manuscript.

Shared Material: As a condition of publication, cell lines, hybridomas, DNA clones, antibodies, biological reagents and animal models described in papers published in JBMR will be made available to scientists in non-commercial institutions for purposes of replicating the reported studies.

Review Process

The Editorial team has now established a triage process under which all manuscripts undergo an initial review by the editorial staff, including the Editor and at least one Associate Editor, to ensure the paper meets certain criteria. Under this scheme, approximately 15% of new submissions may be returned to the authors without formal review, for reasons that may include:

• insufficient direct relevance to bone biology and mineral metabolism,
• inadequate or unethical methodology,
• inadequate statistical power or assessment,
• insufficient innovation or contribution to the advancement of the field.

All other manuscripts will undergo the full peer review process, being referred to an Associate Editor, who will identify reviewers with the expertise to review the paper. At each Associate Editor's discretion, any manuscript may be referred specifically for statistical review relating to the appropriateness or otherwise of statistics used, adjustment for multiple comparisons, sample size issues and the like. Manuscripts with inadequate or inappropriate statistics will not be accepted. Authors are encouraged to suggest names of appropriate reviewers (include phone/fax/address/e-mail for each reviewer suggested) and may also request that a specific reviewer not be used.

Authors will receive a full response on their manuscript detailing any changes required by the Reviewers and Editorial team and the decision about the acceptance or otherwise of the manuscript. Only authors listed on the manuscript may receive information about a manuscript.

Authors who wish to object to an unfavorable decision must do so within two months of notification of a decision. Please note all communications must be directed to the Editor-in-Chief and sent to the ASBMR Publications Office via email (manuscript@asbmr.org).

Accepted Article Publication

Papers accepted for publication in JBMR are first published online before they are finally published in the print Journal. The papers included on JBMR as Accepted Articles are posted upon acceptance and are not copyedited before posting. The papers will appear as manuscript pages. The date of Accepted Article publication is considered the publication date of release into the public domain. Only typographical errors can be revised for Accepted Article publication.

In order to prepare the paper for print publication, the paper will be copyedited and the authors will be able to view proofs of the manuscript as usual before the paper is finally published. The paper will be published in its final format in print and this version will also replace the Accepted Article (unedited) version online. Please note that Accepted Article publication makes it incumbent upon the authors to submit their revisions with little or no alterations necessary.

Authors can choose to have their papers posted online within 3-5 days after acceptance or can choose to delay publication of the paper until the paper has been through the normal copyediting process and is published in print. Authors should note their choice on the Copyright Transfer Agreement form that is submitted with the manuscript. The Institute for Scientific Information (ISI) cannot currently track the citations to articles that are posted online and not in a regular issue. Like most journal publishers, we support the ISI in working to capture this information for authors and will post any change in status on the JBMR website.

Types of Submissions Accepted

Original Studies: Reports of original research of interest to the bone and mineral community are the primary material to be published as original studies. Studies of bone and cartilage biology and mineral homeostasis including regulatory factors and pathways, pathophysiology, molecular biology and physiology, genetics, epidemiology and clinical trials of new agents and in new clinical situations. Manuscripts should be submitted to our online system at http://jbmr.editorialmanager.com/.

Reviews: Reviews are wide-ranging overviews of a field of research. To achieve a wider perspective they are expected to come from more than a single group. Reviews will not normally be accepted from a single individual or team. They should review where a particular field has developed and what are the outstanding issues and challenges. Reviews may be solicited or proposed. Proposed reviews must be approved by the Editor-in-Chief prior to submission. JBMR will not review reviews that have not been approved by the Editor-in-Chief. Please note that any Review will be subject to the standard review process. Manuscripts should be submitted to our online system at http://jbmr.editorialmanager.com/.

Perspectives: Perspectives focused mini-reviews and may be accepted from a single individual or team. Proposed perspectives must be approved by the Editor-in-Chief prior to submission. The JBMR will not review perspectives that have not been approved by the Editor-in-Chief. Perspectives should review a particular field to identify outstanding issues and challenges and propose new hypotheses. Please note that any Perspective will be subject to the standard review process. Manuscripts should be submitted to our online system at http://jbmr.editorialmanager.com/.

Key overviews: Overviews of major areas will be commissioned by the Editorial team and may be proposed by Authors. Conceptual diagrams are encouraged in such overviews. All such overviews, even when commissioned, will be subject to full review. Manuscripts should be submitted to our online system at http://jbmr.editorialmanager.com/.

Case Reports and Clinical Vignettes: JBMR encourages the submission of case reports and clinical vignettes that provide new and exciting insights into the pathophysiology and characteristics of disorders related to skeletal function and mineral metabolism and/or highlight practical diagnostic and/or therapeutic considerations. In general case reports should be limited to one printed page (text and figures); color figures will incur additional charges of $900 per printed page with color. Clinical Vignettes should be 4-5 pages, including figures. The format of these papers should follow that described in the “Preparation of Manuscript" section below with the added consideration of providing case historical data as appropriate. Page charges/submission fees apply as indicated below (see "Author Fees"). Identifying information within written descriptions, photographs, or pedigrees should not be published. If such information is included as essential scientific information, the authors must submit written consent of the patient, parent, or guardian as applicable to publish such photographs in JBMR. Case reports should be submitted to our online system at http://jbmr.editorialmanager.com/.

Clinical Trials: A clinical trial is an original research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials (also called medical research and research studies) are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. Manuscripts should be submitted to our online system at http://jbmr.editorialmanager.com/.

Letters to the Editor: JBMR accepts Letters to the Editor that probe issues raised in published articles and that address issues of general importance in the areas of musculoskeletal function and mineral metabolism. While not all Letters to the Editor will be published, those that are judged worthwhile will be forwarded to the authors of the manuscript in question or to selected experts in order to provide the opportunity for a response to appear. Letters to the Editor should be submitted to our online system at http://jbmr.editorialmanager.com/.

Raisz-Drezner JBMR First Paper Awards: The American Society for Bone and Mineral Research (ASBMR) is proud to announce the ASBMR Raisz-Drezner Journal of Bone and Mineral Research First Paper Awards. This junior investigator recognition program was developed to honor first authors of first scientific publications published in JBMR. The award is named after the Journal's first two Editors-in-Chief, Lawrence Raisz and Marc Drezner.
 
Eligibility
To qualify for consideration for this award in 2010, a paper must:

1. Be the first peer reviewed scientific publication where the first author appears as first author.
2. Have been accepted by the JBMR between July 1, 2009, and June 30, 2010.
3. Be accompanied by a cover letter confirming the status of the first author as hitherto unpublished in the scientific literature as a first author of a peer reviewed paper.

Process
Papers accepted for publication in JBMR, that were submitted according to the three guidelines above, will be submitted to the review committee. No additional application is required. The review committee will include JBMR Associate Editors, Editor-in-Chief Thomas Clemens, and past Editors-in-Chief Lawrence Raisz, Marc Drezner, and John Eisman.

Award Presentation
The award is ordinarily presented at the President's Reception during the ASBMR Annual Meeting. The awardee will receive a plaque and $1,000.

Submitting a Manuscript

If you have questions regarding any of the requirements for submitting a manuscript to JBMR, please email the ASBMR Publications Office at manuscript@asbmr.org (fax US 202.367.2156; ph US 202.367.1161).

Editorial Manager^TM Online Submissions and Review System

All manuscripts must be submitted to the JBMR electronic submission and review system at http://jbmr.editorialmanager.com/. Full instructions for on-line submission are available on the Editorial Manager site and on jbmronline.org. Click on “Instructions for Authors” in the menu. Then click on "Instructions for using the Editorial Manager Submission and Review System.” Upon receipt of a manuscript, an e-mail message will be sent to the corresponding author confirming receipt of the paper. If you do not receive this confirmation within 48 hours, please email the ASBMR Publications Office to confirm receipt.

Manuscript Format

We wish to emphasize the importance of clarity and succinctness of the presentation of material:

• Please respect the relevance of all material to the Introduction, Methods, Results and Discussion and avoid unnecessary repetition.
• Do not repeat the results and conclusions in the Introduction.
• Conclusions should NOT be stated throughout the Results section.
• Results should not be restated throughout the Discussion section.
• Avoid simply restating the Results in the Discussion rather than explaining how each result advances the overall conclusions of the study.
• The final part of the Discussion should refer back to the rationale for the study and explain how the findings have advanced the area.
• Do not embed your figures within your manuscript file.

We strongly recommend authors employ the format and guidelines detailed below.

Abbreviations and Nomenclature: Abbreviations and nomenclature should follow the recommendations of the International Union of Pure and Applied Chemistry and the International Union of Biochemistry [see http://www.chem.qmul.ac.uk/iupac/jcbn/]. The International system of Units (SI units) is recommended. It is desirable to include appropriate conversion factors to aid the reader. The list of abbreviations in Endocrinology 138:1 (January 1997) is generally acceptable in JBMR. Drug names should always be generic.

Bone Histomorphometry: Papers on bone histomorphometry should use the nomenclature, symbols, and units described in the Report of the American Society of Bone and Mineral Research Committee (JBMR 2:595-610, 1987) which is available in PDF form by clicking here.

Tumor Necrosis Factor: Papers on tumor necrosis factor (TNF) should use the nomenclature described in the Report of the American Society of Bone and Mineral Research Committee. (JBMR 15:2293-2296, 2000) and available on the JBMR website (http://www.jbmr.org/).

Authors Copyright Assignment

Each author of the manuscript is required to sign the Author's copyright agreement and consent form and must submit his or her academic qualifications, email address and individual key words (see the following JBMR key words at the end of the “Instructions to Authors” and available on line). All Authors of a manuscript should be listed in the submission process, registered on the Editorial Manager web site (http://jbmr.editorialmanager.com/) and their personal classifications designated. Failure to provide this information will delay processing of the manuscript. Please note that all corresponding authors must notify their co-authors of the decision on their paper and there cannot be more than one corresponding author per manuscript. Authors must also designate on the authors' agreement form whether or not they want their paper to appear on the JBMR WebFirst before print publication. This form should be faxed to ASBMR (202) 367-2156 or mailed to ASBMR, Publications Office, 2025 M Street, NW, Suite 800, Washington, DC 20036 USA.

Manuscript Category

When submitting a paper on Editorial Manager, the submitting author must choose one of the three categories listed below to describe the manuscript.

Basic: A study almost entirely limited to in vitro studies of cell biology, molecular biology and the like.

Clinical: A study with the major component of the focus of the work involving human subjects even if some parts of the study involve laboratory tests including genotyping, pathology, etc.

Translational: Any study involving predominantly animal models or where the laboratory and clinical aspects of a human study are of approximately equal weight.

Page Limitations

Manuscripts over 8 pages are discouraged and any published manuscript over 8 pages will incur extra page charges. Page charges for published manuscripts are $60 per page up to 8 pages. Any pages above 8 will be billed at $120 per page.

Three manuscript pages (double-spaced, 8.5 x 11 inch paper, font size of 12) usually equals one published page. Therefore, submitted manuscripts must be no longer than 24 pages or 8,500 words (about 39,000 characters of text). This includes the text of the manuscript as well as any references, figures or tables. Please calculate your printed pages based on the following guidelines.

Any manuscript that exceeds the page limitations must be accompanied by a letter to the editor providing a detailed account of the components that comprise the excess, in order that the editors and editorial staff may evaluate the manuscript's length and assist the authors in making reductions as necessary.

Title Page, Author's Names, Abstract: one-half published page

Text: Double-spaced on 8 1/2 x 11 inch paper, font size 12 point. Three text pages are equivalent to one published page.

References: Forty-five references are equivalent to one published page.

Figures: one figure is equivalent to one-quarter to one-half a published page or 200-350 words.

Tables: one-half to one published page.

Figure Limitations
The JBMR allows for a maximum of 7 figures. Multi-part figures that exceed one page count against the maximum limit. Manuscripts that exceed the maximum number of figures will be returned to the author without review. A manuscript may contain no more than 7 figures and 7 pages of figures.  Tables do not count against these limitations.
 
Supplemental Data
Authors may submit supporting material to accompany their article for online-only publication when there is insufficient space to include the material in the print article. This material should be important to the understanding and interpretation of the report and should not repeat material in the print article, and it should be original and not previously published.

Online-only material will undergo editorial and peer review with the main manuscript, and will be accepted for publication at the discretion of the editors. This material will not be edited or formatted; thus, authors are responsible for the accuracy and presentation of all such material.

Order

Title Page, Conflict of Interest Page, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Tables, Figures. (Number ALL pages consecutively).

Title page
Authors' names and affiliations

All funding sources supporting publication of a work or study

A running title of no more than 45 characters

Each author's email address

Corresponding author's name, street address, phone, fax numbers and email addresses.

Number of Words/Characters in abstract and manuscript

Number of Figures (Color and Black/White counted separately)

Conflict of Interest Page

Authors should disclose all financial interests, direct or indirect (dual commitment) that might be construed as affecting the conduct or reporting of the work they have submitted. They could be in the form of corporate appointments, consultancies, stock ownership, other equity interests or patent licensing arrangements. The conflict of interest page should take the form of a statement such as the one below. If no author has a conflict, the statement should read: All authors have no conflicts of interest.

Example:

Conflict of interest: Dr. Wheels serves as a consultant for X company, Dr. Staples is an employee of Y Company and Dr. Chip owns stock in Company Z. All other authors have no conflicts of interest.

Abstract
The entire Abstract should not be more than 250 words.

The abstract should be self-explanatory without reference to the text.

Five key words should be listed at the bottom of the abstract page.

Introduction

This should clearly and concisely review the rationale for the study and identify what issues were going to be addressed. It should clearly place the report within the area being studied. It should not describe the outcome of the study (in any detail).

Materials and Methods

This section should carefully describe the methods and materials used including sample size and statistical approaches. Commonly used techniques should be referred to appropriate references and not described in detail. However, unique experiments should be described in adequate detail to allow repetition by others. Sequence and source of unique constructs etc should be made available to other scientists to allow repetition (see section on Shared Material under Editorial Policies and Practices). The role of any outside organization in the collection of data, its analysis and interpretation and/or in the right to approve or disapprove publication of the finished manuscript must be described in the Methods section of the text. Any limitation to the full access of the Authors to all material must be disclosed, although such limitation may lead to failure to accept the manuscript. This is particularly important for any manuscripts detailing work supported in part or entirety by a pharmaceutical or instrument manufacturer/supplier. The sources of materials should be shown by supplier but, with the internationalization of many suppliers, geographical origin, i.e., city, state and country, are NOT required except for smaller perhaps local suppliers.

Results

This section should succinctly state the results without any lengthy discussion or interpretation of individual data. Conclusions presented as declarative headings are not preferred. Extensive conclusions do not belong in the Results section.

Where possible, data should be presented in graphical rather than tabular format. Small tables may best be incorporated into the text. Tabular data should not repeat that shown in the Graphs. Graphs should start the y axis at 0 or show a clear scale break in those cases where starting at 0 would be difficult. The numerals on graph scales should be sufficiently large and clear enough and spaced to allow the data to be interpreted and the nature of the scale, eg linear or log, readily appreciated. The scale numerals should be easily readable, even when printed at the reduced size that figures will usually be printed, ie column width.

Statistical tests should be clearly defined and statistical significance should be shown in both figures and tables by superscripts of a, b, c, rather than *, ¶, # or other non-sequential symbols.

Data in text or tables should be shown to numbers of significant digits consistent with the accuracy of each individual measurement and biological relevance. For example weight, usually measured to the nearest 0.5 kg, should be shown in mean and SD to at most one significant digit after the decimal point.

Discussion

The Discussion should summarize but not repeat the Results and should distinguish between logical explanations of the results reported and extrapolations or hypotheses drawn from the results.

The Discussion should end with a succinct summary of the data and conclusions AND should put the findings into the context of the reason for the study as outlined in the Introduction. Where possible and reasonable, some conclusion should be made about the wider implications of the study findings.

Acknowledgments: Authors are responsible for obtaining and submitting to the editorial office written permission from anyone (with a MD or a PhD) named in the Acknowledgments section. Authors should acknowledge in the manuscript all support for the work, including funding, equipment and drugs.

Manufacturer Name: Please provide the manufacturer name of all products used in paper. Geographical location is not necessary unless it is a specific, perhaps local supplier.

References
Authors are responsible for the accuracy of the references and significant errors in reference accuracy and/or style will delay publication of an accepted manuscript. Do not list references in alphabetical order, but list and number them as they appear in the paper. If it is necessary to cite an abstract, this should be so designated.

References should be presented in the following style. The reference that is used in the research for the paper (online or print) should be the reference listed.

Journal articles: Horton MA, Rimmer EF, Chambers TJ. Giant cell formation in rabbit long-term bone marrow cultures: Immunological and functional studies. J Bone Miner Res. 1986; 1:5-14..

Articles in books: Boyde A.  Scanning electron microscope studies of bone. In: Bourne GH (ed.) The Biochemistry and Physiology of Bone, 2nd ed., 1972; vol. 1. Academic Press, New York, NY, USA, pp. 259-310.

Books (entire): Boyde A. The Biochemistry and Physiology of Bone, 2nd ed., 1972; vol. 1. Academic Press, New York, NY, USA.

References to Online Material

Online journal: Horton MA, Boyde A, Rimmer EF What is it all about? Arch Pediatr Adolesc Med [serial online] Available at: http://www.ama-assn.org/sci-pubs.html. Accessed November 10, 2001.

Online reference (website information, not journal related): Williams A, Lea A, Allen D Kidneys and Cartwheels. Available at: http://www.science.com/. Accessed November 10, 2001.

References to articles published online before print

Meckley T, Reed Y, Greenfield R. Giant cell formation in rabbit long-term bone marrow cultures. J Bone Miner Res. 2003; Published online October 13, 2003; doi:10.1359/JBMR.0303011.

Once the paper is published in the print version, it should be cited as follows:

Meckley T, Reed Y, Greenfield R. Giant cell formation in rabbit long-term bone marrow cultures. J Bone Miner Res. 2003; 18:256-270. Published online October 13, 2003; doi:10.1359/JBMR.0303010.

Figures and Tables
Tables and illustrations should complement and not reiterate the text. No manuscript should contain an excess of 7 figures. Any manuscript submitted with more than 7 figures will be returned to the authors without review. Tables/ illustrations should not include data that can be given in the text in one or two sentences. Each large figure may comprise about one-half printed page and a smaller figure about 1/4 of page. Type each table on a separate sheet of paper. Use Arabic numerals to number tables. (The authors must pay for publication of color illustrations in accordance with the Society's cost schedule. Current charges are $900 (U.S.) per page with color, in addition to the usual page charges.) Multi-part figures must be labeled (i.e. A,B,C). Please use small non-bold, non-italic capital letters and place them in Arial font when using figure headings/labelings. Guidelines for Submission of Digital Art are available on the home page of the Editorial Manager online submissions site (http://jbmr.editorialmanager.com/).

Each table must contain all necessary information in the caption, and the table itself must be understandable independently of the text. Details of experimental conditions should be included in the table footnotes, although this should not unnecessarily repeat information in the Methods.

The authors must obtain permission to reproduce figures, tables, text, and abstracts from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher or the sponsoring society, not the author) of the journal or book concerned. An appropriate credit line should be included in the figure legend or table footnote, and full publication information in the reference list. Written permission must be obtained from the author of any unpublished material cited from other laboratories, and should accompany the manuscript.

Figure Legends: A separate list of figure legends should be supplied at the end of the manuscript. Most figures will be set at single column width (approximately 3-1/8 inches). Please submit figures that are close to publication size to insure that clarity and legibility will be maintained when the figure is reproduced/reduced in size. Figure legends should be brief and should not restate information already in the Materials and Methods section.

Revised Manuscripts

We will make every effort to reduce the time between submission and first response and between submission of revised manuscript and second response. In general, failure to adequately deal with issues raised by reviewers with one revision will preclude acceptance of a manuscript. If a revision is not submitted within 90 days, the file on that manuscript will be considered closed.

Author Fees

Submission Fees: A non-refundable manuscript submission charge of $50 (U.S.) for all new manuscripts should be made payable to the American Society for Bone and Mineral Research. Checks or money orders must be mailed to the editorial office along with the author's agreement form (found on the back inside cover of any issue of the JBMR or at the website http://www.jbmronline.org/). Checks must be drawn on a U.S. bank or a U.S. branch of a non-U.S. bank. Purchase orders will not be accepted for submission fees. We will accept credit cards. Those payments require card number, cardholder's name and signature as it appears on the card, and the expiration date. To pay by credit card, please fax the above information to the ASBMR Publications Office at (202) 367-2156.

Page Charges: If the paper is accepted for publication, page charges, currently $60 (U.S.) per printed page must be paid by all groups of Authors who have funds available from research grants or from their institutions. Payments for page charges up to 8 pages are not a prerequisite for publication of any article if the authors do not have funding for page charges; however, authors must request a waiver in writing to the ASBMR Publications Office prior to the publication of the manuscript. Any manuscript over 8 printed pages will incur mandatory page charges of $120 (U.S.) per page.

Color Charges: Authors are required to pay for publication of color illustrations. Color charges are $900 per page of color. Manuscripts should be submitted with figures as they will be reproduced if accepted for publication. If the authors wish to have the figures published in black and white, the black and white figures must be submitted with the revised manuscript. Color illustrations should only be submitted if the authors will pay the possible color charges if the paper is accepted for publication. Color figures will not be converted to black and white without re-review.

 

Key Words	EXERCISE
AGING	Bone
ANIMAL MODELS	Joint
Bovine/Ovine	Muscle
Canine	GENE/GENETIC RESEARCH
Rodent	Association
Primate	Linkage
Other	SNPs, Polymorphisms
ARTHRITIS	Arrays
Inflammation	Isolation
CALCITONIN	Knock-out/in
CHONDROCYTE, EPIPHYSIS AND CARTILAGE BIOLOGY	GROWTH AND DEVELOPMENT
CLINICAL TRIALS	Clinical/Pediatrics
DISORDERS OF CALCIUM/PHOSPHATE METABOLISM	Growth plate
Parathyroid	Patterning of the limb
Humoral Hypercalcemia of Malignancy	Modeling and remodeling
Magnesium	Molecular pathways
Nephrolithiasis	HORMONES & RECEPTORS
Familial Hypocalciuric Hypercalcemia	Androgens & SARMs
EPIDEMIOLOGY	Calcitonin
Evidence/Guidelines	Chemokines
Population Studies	Corticosteroids
Meta-Analysis	Cytokines
Pharmacogenomics	Estrogens & SERMs
Health Services & Economics	Growth Factors
ION TRANSPORT	Neural factors/Leptin
MATRIX PROTEINS	PTH/PTHrP
Collagen	Vitamin D
Integrins	PARATHYROID HORMONE AND PARATHYROID GLAND
Non-collagenous proteins	Familial Hyperparathyroidism
Osteocalcin	Hypoparathyroidism
Osteopontin	Pseudohypoparathyroidism
Proteoglycans	QUANTITATION
MENOPAUSE	Body composition
METABOLIC BONE DISEASE	Bone densitometry
Osteogenesis Imperfecta	Bone histomorphometry
Osteopetrosis	Bone mineralization
Osteomalacia	Bone QCT
Rickets	Bone scintigraphy
NUTRITION	Bone turnover markers
OSTEOBLASTS & STEM CELLS	Bone ultrasound
Apoptosis	Radiology
Stromal Cells	STATISTICAL METHODS
Osteoblasts	TEETH & DENTAL APPLICATIONS
OSTEOPOROSIS	TRANSCRIPTIONAL FACTORS
Corticosteroid osteoporosis	TREATMENTS
ORTHOPAEDICS	Bisphosphonates
Biomechanics	Strontium
Bioengineering	Fluoride
Mechanical Loading	SERMs
Implants	Vitamin D
Stress/strain	Novel entities
PAGET'S DISEASE
PARACRINE SIGNALING
BMP/SMAD
Wnt/Frz/LRP5
Hedgehog

 

REPRINTS: Reprints may be ordered by using the special reprint order form that will accompany the proofs. (Please note that the address for ordering reprints, which is on the order form, is different from the address to which you return your proofs.)

The JOURNAL OF BONE AND MINERAL RESEARCH is published monthly by The American Society for Bone and Mineral Research, 2025 M Street, N.W., Suite 800, Washington, DC 20036-3309. Telephone (202) 367-1161; Fax (202) 367-2156
 

Site Footer

• Privacy Policy
• Terms of Service
• Copyright
• Wiley.com